MYC and breast cancer: In addition, GP88 stimulates c-myc phosphorylation by affecting mitogen-activated protein kinase (MAP kinase ERK1/2) and the phosphatidyl-inositol-3-kinase (PI3K) pathways and stimulates src phosphorylation in breast cancer cells [24].